Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
A rating scale for drug-induced akathisia.
- T. Barnes
- Psychology, Medicine
- The British journal of psychiatry : the journal…
- 1 May 1989
A rating scale for drug-induced akathisia has been derived that incorporates diagnostic criteria for pseudoakathisia, and mild, moderate, and severe akathisia. It comprises items for rating the… Expand
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
- T. Moore, S. Zammit, A. Lingford-Hughes, T. Barnes, G. Lewis
- Medicine
- The Lancet
- 28 July 2007
BACKGROUND
Whether cannabis can cause psychotic or affective symptoms that persist beyond transient intoxication is unclear. We systematically reviewed the evidence pertaining to cannabis use and… Expand
A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication.
- T. Sensky, D. Turkington, +5 authors T. Barnes
- Psychology, Medicine
- Archives of general psychiatry
- 1 February 2000
BACKGROUND
Research evidence supports the efficacy of cognitive-behavioral therapy in the treatment of drug-refractory positive symptoms of schizophrenia. Although the cumulative evidence is strong,… Expand
Frontal-striatal cognitive deficits in patients with chronic schizophrenia.
- C. Pantelis, T. Barnes, +4 authors T. Robbins
- Psychology, Medicine
- Brain : a journal of neurology
- 1 October 1997
Spatial working memory and planning abilities were assessed in 36 hospitalized patients with chronic schizophrenia, using the computerized Cambridge Neuropsychological Test Automated Battery… Expand
Comorbid substance use and age at onset of schizophrenia
- T. Barnes, S. Mutsatsa, S. Hutton, H. Watt, E. Joyce
- Medicine, Psychology
- British Journal of Psychiatry
- 1 March 2006
Background Substance use may be a risk factor for the onset of schizophrenia. Aims To examine the association between substance use and age at onset in a UK, inner-city sample of people with… Expand
Comorbidity of substance misuse and mental illness in community mental health and substance misuse services
Background Improved management of mental illness and substance misuse comorbidity is a National Health Service priority, but little is known about its prevalence and current management. Aims To… Expand
Executive function in first-episode schizophrenia.
- S. Hutton, B. Puri, L. Duncan, T. Robbins, T. Barnes, E. Joyce
- Psychology, Medicine
- Psychological medicine
- 1 March 1998
BACKGROUND
We tested the hypothesis that schizophrenia is primarily a frontostriatal disorder by examining executive function in first-episode patients. Previous studies have shown either equal… Expand
Do patients with schizophrenia exhibit aberrant salience?
- J. Roiser, K. Stephan, H. den Ouden, T. Barnes, Karl J. Friston, E. Joyce
- Psychology, Medicine
- Psychological medicine
- 30 June 2008
Background It has been suggested that some psychotic symptoms reflect ‘aberrant salience’, related to dysfunctional reward learning. To test this hypothesis we investigated whether patients with… Expand
A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs
- T. Barnes
- Psychology
- British Journal of Psychiatry
- 1 May 2000
This is a book written by a man with a mission: to improve clinicians' awareness of extrapyramidal side-effects and their relevance in routine clinical practice, and encourage systematic… Expand
Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia
- L. Garey, W. Ong, +5 authors S. Hirsch
- Psychology, Medicine
- Journal of neurology, neurosurgery, and…
- 1 October 1998
OBJECTIVE A pilot study of the density of dendritic spines on pyramidal neurons in layer III of human temporal and frontal cerebral neocortex in schizophrenia. METHODS Postmortem material from a… Expand
...
1
2
3
4
5
...